Anavex Life Sciences Corp. (AVXL)
NASDAQ·Healthcare·Biotechnology
$2.34
-5.26%
Mkt Cap $224.27M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$11.00
Range $11.00 – $11.00
Implied Upside
+370.1%
Consensus $11.00 vs current $2.34
NASDAQ·Healthcare·Biotechnology
$2.34
-5.26%
Mkt Cap $224.27M
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$11.00
Range $11.00 – $11.00
+370.1%
Consensus $11.00 vs current $2.34